Home
Roche NimbleGen

Roche NimbleGen Market Share Analysis for April 2026

Science and Education > Biology

Domainnimblegen.com

Year Founded1999

Employees51 - 200

Annual Revenue$2M - $5M

Roche NimbleGen

Roche NimbleGen (including company regionals)

nimblegen.com

See more website traffic and engagement information

Roche NimbleGen Revenue up to April 2026 is 2M - 5M

revenue generated by Roche NimbleGen top domains

Roche NimbleGen top domains revenue over 3 years

Revenue for Roche NimbleGen top domains

nimblegen.com2M - 5M

See more with Sales Intelligence

Total visits to Roche NimbleGen's top domains

Understand Roche NimbleGen market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Roche NimbleGen's top domains

Analyze Roche NimbleGen engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Roche NimbleGen's top domains

See how Roche NimbleGen keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Roche NimbleGen top competitors by domain

Top similar sites in April 2026, ranked by their affinity

affymetrix.comCompany NameAffymetrixEmployees1001 - 5000HQGermany, Santa ClaraAnnual revenue$200M - $500MTotal visits511Science and Education > Biology

Top technologies used by Roche NimbleGen

These are the website technologies, by industry, used by Roche NimbleGen top domains

Advertising (3)

DoubleClick

Conversion & Analytics (3)

Google Analytics

Mobile (2)

Meta Viewport

Widget (2)

reCAPTCHA

More Technologies

4

See all

News & Signals from Roche NimbleGen

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRoche acquired Nimblegen for $250M on Jan 1st '07.In 2007, Roche acquired NimbleGen, which was among the first biotech companies to launch microarrays and hybridization probes (SeqCap Portfolio) for target enrichment.